XEM:CA:TSX-iShares MSCI Emerging Markets Index ETF (CAD)

ETF | Emerging Markets Equity |

Last Closing

CAD 33.78

Change

+0.96 (+2.93)%

Market Cap

CAD 0.20B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Emerging Markets Equity

Symbol Name Price(Change) Market Cap
XSEM:CA iShares ESG MSCI Emerging Mark..

+0.55 (+2.64%)

CAD 3.14B
XEC:CA iShares Core MSCI Emerging Mar..

+0.76 (+2.64%)

CAD 1.74B
ZEM:CA BMO MSCI Emerging Markets Inde..

+0.59 (+2.73%)

CAD 1.01B
DRFE:CA Desjardins RI Emerging Markets..

+0.32 (+1.39%)

CAD 0.08B
XMM:CA iShares MSCI Min Vol Emerging ..

+0.46 (+1.55%)

CAD 0.06B
RXD:CA RBC Quant Emerging Markets Div..

+0.40 (+1.92%)

CAD 0.04B
MEE:CA Mackenzie Maximum Diversificat..

+0.62 (+2.48%)

N/A
VEE:CA Vanguard FTSE Emerging Markets

+1.08 (+2.91%)

N/A
ZLE:CA BMO Low Volatility Emerging Ma..

+0.41 (+2.14%)

N/A

ETFs Containing XEM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Emerging Markets Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.66% 50% F 63% D
Dividend Return 0.59% 29% F 18% F
Total Return 15.25% 40% F 59% D-
Trailing 12 Months  
Capital Gain 19.20% 50% F 57% F
Dividend Return 2.45% 63% D 43% F
Total Return 21.64% 40% F 56% F
Trailing 5 Years  
Capital Gain 10.75% 40% F 45% F
Dividend Return 7.40% 33% F 34% F
Total Return 18.15% 50% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 1.02% 20% F 41% F
Dividend Return 2.55% 40% F 42% F
Total Return 1.54% 60% D- 48% F
Risk Return Profile  
Volatility (Standard Deviation) 15.51% 40% F 53% F
Risk Adjusted Return 16.48% 30% F 39% F
Market Capitalization 0.20B 57% F 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.